Filing Details
- Accession Number:
- 0001209191-21-038690
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-07 17:06:19
- Reporting Period:
- 2021-06-03
- Accepted Time:
- 2021-06-07 17:06:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1404644 | Neoleukin Therapeutics Inc. | NLTX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1588467 | G Jonathan Drachman | C/O Neoleukin Therapeutics, Inc. 188 East Blaine Street, #450 Seattle WA 98102 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-06-03 | 40,000 | $9.48 | 2,238,686 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-06-04 | 10,000 | $9.61 | 2,248,686 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Represents the weighted average purchase price. The lowest price at which shares were purchased was $9.38 and the highest price at which shares were purchased was $9.51. The reporting person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- Represents the weighted average purchase price. The lowest price at which shares were purchased was $9.56 and the highest price at which shares were purchased was $9.62.